Biomarkers Overview
JH · Effective Oct 1, 2015
54 active Medicare policies list 81406, and 39 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Jul 17, 2023
JH · Effective Jul 17, 2023
JL · Effective Jul 17, 2023
J15 · Effective Aug 21, 2022
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
39 policies from 6 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 15 · All Ambetter policies
| Policy | Effective | Status of 81406 |
|---|---|---|
| Concert Genetic Testing: Cardiovascular | Not recorded | Referenced |
| Concert Genetic Testing: Endocrinology | Not recorded | Referenced |
| Concert Genetic Testing: Gastroenterology | Not recorded | Referenced |
| Concert Genetic Testing: Hematology | Not recorded | Referenced |
| Concert Genetic Testing: Hereditary Cancer |
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J15 · Effective Aug 3, 2020
JE · Effective Aug 17, 2020
JF · Effective Aug 17, 2020
JJ · Effective Jul 26, 2020
JM · Effective Jul 26, 2020
J5 · Effective Jul 26, 2020
J8 · Effective Jul 26, 2020
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6 · Effective Jul 13, 2025
JK · Effective Jul 13, 2025
J9 · Effective Dec 12, 2021
JH · Effective Dec 12, 2021
JL · Effective Dec 12, 2021
National · Effective Aug 6, 2026
National · Effective Aug 13, 2026
National · Effective Aug 6, 2026
J5 · Effective Aug 6, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
J5 · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Nov 13, 2025
J5 · Effective Jul 1, 2026
JL · Effective Jul 1, 2026
J9 · Effective Jul 1, 2026
J6 · Effective Jul 15, 2026
J6 · Effective Apr 1, 2026
JL · Effective Sep 10, 2026
J9 · Effective Sep 10, 2026
| Not recorded |
| Referenced |
| Concert Genetic Testing: Immunology and Rheumatology | Not recorded | Referenced |
|---|
| Concert Genetic Testing: Multisystem Genetic Conditions | Not recorded | Referenced |
|---|
| Concert Genetic Testing: Nephrology | Not recorded | Referenced |
|---|
| Concert Genetic Testing: Neurology | Not recorded | Referenced |
|---|
| Concert Genetic Testing: Nutrition and Metabolism | Not recorded | Referenced |
|---|
Showing 10 of 12 · All Regence BCBS policies
| Policy | Effective | Status of 81406 |
|---|---|---|
| Expanded Molecular Testing of Cancers to Select Targeted Therapies | Jul 1, 2026 | Covered |
| Genetic Testing for Alzheimer's Disease | Jun 1, 2026 | Covered |
| Genetic Testing for Biallelic RPE65 Variant-Associated Retinal Dystrophy | Jun 1, 2026 | Covered |
| Genetic Testing for CADASIL Syndrome | Jun 1, 2026 | Covered |
| Genetic Testing for Epilepsy | Jan 1, 2026 | Covered |
| Genetic Testing for Familial Hypercholesterolemia | Mar 1, 2026 | Covered |
| Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis Syndromes | Feb 1, 2026 | Covered |
| Genetic Testing for Primary Mitochondrial Disorders | Mar 1, 2026 | Covered |
| Genetic Testing for Rett Syndrome | Nov 1, 2025 | Covered |
| Genetic Testing for the Diagnosis of Inherited Peripheral Neurophathies | May 1, 2026 | Covered |
| Policy | Effective | Status of 81406 |
|---|---|---|
| Alzheimer's Disease Tests | Sep 8, 2023 | Covered |
| Endolymphatic Hydrops (Meniere's Disease) Tests | Aug 11, 2023 | Covered |
| Genetic Testing | Feb 27, 2024 | Covered |
| Infertility | Feb 15, 2024 | Covered |
| RET Proto-Oncogene Testing | May 8, 2023 | Covered |
| Tumor Markers | Mar 5, 2024 | Covered |
| Policy | Effective | Status of 81406 |
|---|---|---|
| Carrier Screening in the Reproductive Setting | Sep 19, 2026 | Covered |
| Carrier Screening in the Reproductive Setting | Sep 20, 2025 | Covered |
| Hereditary Cancer Testing | Apr 4, 2026 | Covered |
| Predictive and Prognostic Polygenic Testing | Jun 14, 2026 | Covered |
| Policy | Effective | Status of 81406 |
|---|---|---|
| Cigna Comprehensive Code List | Mar 7, 2026 | Prior auth required |
| Policy | Effective | Status of 81406 |
|---|---|---|
| Tier 2 Molecular Pathology Procedures | Not recorded | Covered |